The importance of individualized pharmaceutical therapy in the treatment of diabetes mellitus

Disease Management

Volumn 4, Issue , 2001, Pages S5-S23

  Nash, David B ^a   Koenig, Jennifer B ^a   Novielli, Karen D ^a   Liberoni, Renee ^a   Reisman, Miriam ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETOHEXAMIDE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; CHLORPROPAMIDE; GLIBENCLAMIDE; GLIBENCLAMIDE PLUS METFORMIN; GLIMEPIRIDE; GLIPIZIDE; INSULIN LISPRO; METFORMIN; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; UNCLASSIFIED DRUG;

COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIET THERAPY; DRUG EFFECT; ENVIRONMENTAL FACTOR; GLUCOSE BLOOD LEVEL; HEALTH CARE QUALITY; HUMAN; INDIVIDUALIZATION; INSULIN TREATMENT; PATIENT CARE; QUALITY OF LIFE; REVIEW; TREATMENT PLANNING;

EID: 0034752310     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/10935070152639036     Document Type: Review

References (56)

1. Diabetes: A serious public health problem
2. Diabetes and its impact on the elderly
3. American Diabetes Association annual meeting 1996: The etiology of type II diabetes, obesity, and the treatment of type II diabetes
4. Nutrition principles and diabetes: A role for "lente carbohydrate"?
5. The elderly as the new consumer of health care
6. Recent advances in the treatment of diabetes mellitus: Special considerations in the elderly
7. Outcomes of patients with hypertension and non-insulin dependent diabetes mellitus treated by different systems and specialties. Results from the medical outcomes study
8. Diabetes mellitus and cardiovascular disease in the older woman
9. Special delivery
10. Diabetes reveals its genes
11. Prevalence of diabetes, impared fasting glucose, and impaired glucose tolerance in U.S. adults
12. Type 2 diabetes in children and adolescents
13. Disease management: Balancing cost and quality. Studies on the benefits of disease management services for the treatment of diabetes
14. Economic consequences of diabetes mellitus in the U.S. in 1997
15. Clinical practice recommendations
16. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
17. The natural history of type 2 diabetes. Implications for clinical practice
18. Implications of the United Kingdom Prospective Diabetes Study
19. New oral therapies for type 2 diabetes
20. Glucosidase inhibitors as agents in the treatment of diabetes
21. Glucovance (Glyburide and Metformin Tablets) approved for type 2 diabetes
22. Continuous subcutaneous insulin infusion therapy for children and adolescents: An option for routine diabetes care
23. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes
24. Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I
25. Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: A Belgian experience
26. American Diabetes Association 60th scientific sessions, 2000: Cardiovascular disease in diabetes
27. Aspirin use among adults with diabetes: Estimates from the Third National Health and Nutrition Examination Survey
28. The prevalence of comorbid depression in adults with diabetes: A meta-analysis
29. Depression is still underrecognized and undertreated
30. The use of antidepressants with elderly patients
31. Effects of nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial
32. Fluoxetine for depression in diabetes: A randomized double-blind placebo-controlled trial
33. Model of complications of NIDDM. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of Normoglycemia
34. Pharmacologic therapy for type 2 diabetes mellitus
35. Efficacy of metformin in the treatment of NIDDM. Meta-analysis
36. 1cafter a physician education project